What are your peers saying about 1stOncology?
One of the top three Japanese big pharma companies benchmarked 1stOncology across all the major services out there and reported that 1stOncology had the best coverage and analysis of immunecheckpoint inhibitors and combination therapies.Big Pharma Client Japan
“1stOncology has really been great and very helpful for our BD team”World-leader in Dx/CDx
“This is so convenient to do analysis systematically and comprehensively, it works very well! I really appreciate all your time and effort in adding this super feature to your insight tool!”Innovative Asian biotech company
“Outstanding service provided by the 1stOncology database!”Global leader in in-vitro diagnostics
Two top tier universities in the US expressed that 1stOncology lets them present the competitive landscape in a very novel and insightful way which differentiate their projects to investors and potential licensing partnersTop Tier Universities
“We have many CI tools, but we always turn to 1stOncology when analyzing oncology”Established European Biotech
“Happy with the database which provides many useful details, and we believe your database is significantly better than other databases we have tried out.”Emerging Scandinavian Biotech
One of the top three Japanese big pharma companies benchmarked 1stOncology across all the major services out there and reported that 1stOncology had the best coverage and analysis of immunecheckpoint inhibitors and combination therapies.
Big Pharma Client Japan
“1stOncology has really been great and very helpful for our BD team”
World-leader in Dx/CDx
“This is so convenient to do analysis systematically and comprehensively, it works very well! I really appreciate all your time and effort in adding this super feature to your insight tool!”
Innovative Asian biotech company
“Outstanding service provided by the 1stOncology database!”
Global leader in in-vitro diagnostics
Two top tier universities in the US expressed that 1stOncology lets them present the competitive landscape in a very novel and insightful way which differentiate their projects to investors and potential licensing partners
Top Tier Universities
“We have many CI tools, but we always turn to 1stOncology when analyzing oncology”
Established European Biotech
“Happy with the database which provides many useful details, and we believe your database is significantly better than other databases we have tried out.”
Emerging Scandinavian Biotech
The Most Comprehensive Tool Available
Our active surveillance covers everything from traditional chemotherapies to precision medicine in cancer.Your Conference Year? Covered!
Executive companion reports and online tools to analyze AACR, ASCO, ASH, BIO, ESMO etc.Invest in Your Career Development
Contribute to your team while furthering your own career development.
A Top 10 Global Pharma Analytic Provider
"Our mission is to deliver a superior intelligence service to cancer drug stakeholders and to make 1stOncology the go- to solution for those who are serious about their investment in oncology"
Insights You Can Trust
Since 1999, BioSeeker Group have been 100% dedicated and focused on oncology and for 20 years now, we have provided our world-wide client base with the scientific and business insights required for time-saving and accurate analysis of competing drug development and corporate strategies. Get the full picture by tapping into our expertise and this wealth of knowledge found no-where else.